These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Polyvalent group B streptococcal immune globulin for intravenous administration: overview. Fischer GW; Hemming VG; Gloser HP; Bachmayer H; von Pilar CE; Wilson SR; Baron PA Rev Infect Dis; 1990; 12 Suppl 4():S483-9; discussion S489-91. PubMed ID: 2194273 [TBL] [Abstract][Full Text] [Related]
3. Effect of intravenous immunoglobulin G on neutrophil kinetics during experimental group B streptococcal infection in neonatal rats. Harper TE; Christensen RD; Rothstein G; Hill HR Rev Infect Dis; 1986; 8 Suppl 4():S401-8. PubMed ID: 3092307 [TBL] [Abstract][Full Text] [Related]
4. Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune globulin to neonates with clinical signs of early-onset sepsis. Christensen RD; Brown MS; Hall DC; Lassiter HA; Hill HR J Pediatr; 1991 Apr; 118(4 Pt 1):606-14. PubMed ID: 1901083 [TBL] [Abstract][Full Text] [Related]
5. Directed immune globulin for the prevention or treatment of neonatal group B streptococcal infections: a review. Fischer GW; Weisman LE; Hemming VG Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S92-7. PubMed ID: 1728993 [TBL] [Abstract][Full Text] [Related]
6. Treatment of experimental group B streptococcal infection with hybridoma antibody. Christensen RD; Rothstein G; Hill HR; Pincus SH Pediatr Res; 1984 Nov; 18(11):1093-6. PubMed ID: 6393022 [TBL] [Abstract][Full Text] [Related]
7. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats. Iguchi K; Inoue S; Kumar A Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109 [TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin therapy of neonatal group B streptococcal infections: an overview. Fischer GW Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S13-6. PubMed ID: 3041355 [TBL] [Abstract][Full Text] [Related]
9. The effect of hybridoma antibody administration upon neutrophil kinetics during experimental type III group B streptococcal sepsis. Christensen RD; Rothstein G; Hill HR; Pincus SH Pediatr Res; 1983 Oct; 17(10):795-9. PubMed ID: 6356000 [TBL] [Abstract][Full Text] [Related]
10. Human immunoglobulins for intravenous use: comparison of available preparations for group B streptococcal antibody levels, opsonic activity, and efficacy in animal models. Givner LB Pediatrics; 1990 Dec; 86(6):955-62. PubMed ID: 2123536 [TBL] [Abstract][Full Text] [Related]
11. Survival and neutrophil kinetics in infants with severe group B streptococcal disease treated with gamma globulin. Friedman CA; Robbins KK; Temple DM; Miller CJ; Rawson JE J Perinatol; 1996; 16(6):439-42. PubMed ID: 8979181 [TBL] [Abstract][Full Text] [Related]
12. Circulating and storage neutrophil changes in experimental type II group B streptococcal sepsis. Christensen RD; Shigeoka AO; Hill HR; Rothstein G Pediatr Res; 1980 Jun; 14(6):806-8. PubMed ID: 6995919 [TBL] [Abstract][Full Text] [Related]
13. Comparison of group B streptococcal hyperimmune globulin and standard intravenously administered immune globulin in neonates. Weisman LE; Anthony BF; Hemming VG; Fischer GW J Pediatr; 1993 Jun; 122(6):929-37. PubMed ID: 8501574 [TBL] [Abstract][Full Text] [Related]
14. Neutrophil transfusions in the treatment of neonatal sepsis. Cairo MS Am J Pediatr Hematol Oncol; 1989; 11(2):227-34. PubMed ID: 2665551 [TBL] [Abstract][Full Text] [Related]
15. Blood and marrow neutrophils during experimental group B streptococcal infection: quantification of the stem cell, proliferative, storage and circulating pools. Christensen RD; MacFarlane JL; Taylor NL; Hill HR; Rothstein G Pediatr Res; 1982 Jul; 16(7):549-53. PubMed ID: 7050869 [No Abstract] [Full Text] [Related]
16. High intravenous doses of human immune globulin suppress neonatal group B streptococcal immunity in rats. Weisman LE; Lorenzetti PM J Pediatr; 1989 Sep; 115(3):445-50. PubMed ID: 2671331 [TBL] [Abstract][Full Text] [Related]
17. Gammaglobulin as a measure for treating neonatal GBS infections. Fischer GW Antibiot Chemother (1971); 1985; 35():237-46. PubMed ID: 3901900 [No Abstract] [Full Text] [Related]
18. Prophylactic or simultaneous administration of recombinant human granulocyte colony stimulating factor in the treatment of group B streptococcal sepsis in neonatal rats. Cairo MS; Mauss D; Kommareddy S; Norris K; van de Ven C; Modanlou H Pediatr Res; 1990 Jun; 27(6):612-6. PubMed ID: 1694023 [TBL] [Abstract][Full Text] [Related]
19. Modified human immune serum globulin for intravenous administration: in vitro opsonic activity and in vivo protection against group B streptococcal disease in suckling rats. Fischer GW; Hunter KW; Wilson SR Acta Paediatr Scand; 1982 Jul; 71(4):639-44. PubMed ID: 6753478 [TBL] [Abstract][Full Text] [Related]
20. Granulocyte transfusions in septic adult and newborn rats: distribution of granulocytes and effect on peripheral blood and bone marrow. Baley JE; Bruce M; Stork EK; Klinger JD; Medvik K; Shurin S J Lab Clin Med; 1990 Mar; 115(3):283-91. PubMed ID: 2313160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]